I searched for help with depression. Now what?

You typed it. Maybe it was "help with depression," maybe just "depressed." You read a few pages, closed the tab, and are now wondering what, if anything, to do next.

This FAQ is for that moment. It is built on our poll of 443 Midwesterners, many of whom described searching in almost exactly the words you may have used. Every number reflects the full sample in its final, validated form.

Is it strange that I searched for a feeling instead of a treatment?

Not at all. It is the norm. Our survey asked for the exact words people would search when they wanted help. Among the 319 replies were "help with mental health" and, more starkly, "someone please help me." Drug names and therapy names simply did not show up in the phrases we quote.

Why did nothing I found feel like it was for me?

Search engines answer the average version of your question. After two or three antidepressants that left you where you started, results full of coping tips and therapist directories may feel beside the point.

Options built for depression that standard treatment has not lifted tend to be described in clinical terms, which is one reason people rarely stumble on them. In our survey, Spravato, an esketamine nasal spray the FDA approved for exactly that kind of depression, was a name 73 percent of respondents could not place at all. You can read how Spravato treatment works in plain terms before raising it with anyone.

Where should I go first?

For most people, a primary care doctor. That is what 56 percent of our respondents said they would do. A psychiatrist would be the first call for 23 percent, and a mere 12 percent said they would keep searching by themselves.

If you have a regular doctor, book a visit and say plainly that your depression is not improving. If you do not, a community health center or community mental health center in your area can often see new patients and may offer sliding fees.

What if I honestly do not know where to start?

You are not alone in that either. Five percent of our respondents said exactly that. A simple starting point is the phone line printed on your insurance card. Ask for in-network mental health providers near you and whether you need a referral. If you are uninsured, ask a local health center for help.

What are the newer options people talk about?

Based on what you have tried, a clinician might bring up changing or adding medications, different forms of therapy, transcranial magnetic stimulation (TMS), or esketamine. You may also see ketamine offered in other ways online. It helps to know the difference:

• Esketamine nasal spray has FDA approval for depression that earlier treatments did not relieve; certified clinics give it, keep you for observation, and require a ride home.
• IV ketamine is offered at infusion clinics as an off-label use for depression.
• At-home ketamine arrives by mail after a video visit, and you take it at home with no clinician beside you.

Only a clinician who has your history can say whether any of these is appropriate.

Does it matter whether a treatment is FDA-approved?

It matters to many people. FDA approval would decide things or count for a lot with 59 percent of the people we polled. If you share that view, ask a provider directly which version of a treatment they offer and what it is approved for.

Will my insurance cover it?

Only your plan can say, so call early. Coverage outweighed every other provider factor in our survey; 85 percent of respondents placed it in their top two.

Our respondents had a wide range of coverage. Commercial insurance and Medicaid were reported at nearly the same rate, 39 and 37 percent, with Medicare at 23 percent. If a treatment is covered, expect that prior authorization may be required. Slightly more than half the people we surveyed would accept those extra steps over paying out of pocket.

Do I have to go to a clinic, or can I do this from home?

It depends on the treatment. The approved esketamine spray is given only in certified settings. Many other kinds of care, including therapy and medication management, can happen by telehealth.

Our respondents leaned toward in-person care. Forty-four percent wanted a clinic for the whole course, telehealth from home suited 22 percent, and 23 percent wanted a clinic start followed by care at home. No preference: 11 percent.

I am skeptical about ketamine. Is that unusual?

No. Skepticism was the second most common first reaction in our survey, at 21 percent. The biggest share, 34 percent, called themselves cautious but open, while 18 percent were hopeful or curious and 9 percent reacted negatively. Bring your questions to a clinician and ask about risks as well as benefits.

Should I tell someone close to me?

If you can, it often helps. Friends and family were the second most persuasive voice in our survey, chosen by 18 percent as the recommendation that would most move them. Someone close can also help with logistics, such as rides to appointments. You do not have to do the searching, or the next step, alone.

What if I am not safe?

If your searches have included thoughts of dying, or if you feel you might act on those thoughts, please reach out now. Text or call 988, at whatever hour, to get the Suicide and Crisis Lifeline; veterans have a press-1 option. Immediate danger is a job for 911.

What this FAQ is not

Think of this FAQ as general information backed by survey data. It is not medical advice and cannot predict any outcome. Please talk with a clinician about what fits your situation.

Methodology

All figures come from one Pollfish survey, sent to its consumer panel; the last answers came in on June 23, 2026. Its 443 respondents, adults 18 to 64, live in Ohio, Minnesota, Nebraska, Illinois, Kansas, Missouri, Indiana, Iowa, Wisconsin, and Oklahoma. The search phrases quoted are from 319 open-ended responses. We report top-line numbers, each from the panel's validated final results. Our publisher commissioned the survey and paid the panel for it.